Location History:
- Lexington, MA (US) (2004 - 2007)
- Plainsboro, NJ (US) (2001 - 2011)
- Carlisle, MA (US) (2017 - 2024)
Company Filing History:
23 out of 125 
12 out of 202 
12 out of 1,309 
Years Active: 2001-2025
Areas of Expertise:
Title: The Innovative Mind of Susan Ashwell: A Pioneering Inventor in Cancer Treatment
Introduction: Susan Ashwell, based in Carlisle, MA, is a distinguished inventor with an impressive portfolio of 26 patents. Her groundbreaking work primarily focuses on innovative therapeutic compositions aimed at treating cancers associated with specific genetic mutations. Susan's contributions to the field of oncology exemplify the impact of targeted therapies and highlight her role as a leading figure in pharmaceutical innovation.
Latest Patents: Among her latest patents, Susan’s notable work includes a method for Inhibiting mutant isocitrate dehydrogenase 1 (mIDH-1). This invention presents a significant advancement for patients diagnosed with cancers harboring an IDH-1 mutation. Her pharmaceutical composition encompasses Compound 1, a selective inhibitor that effectively reduces the production of 2-HG from mIDH-1 enzymes. This groundbreaking patent also addresses various R132 mutations, such as R132C, R132H, R132L, R132G, and R132S, which are critical targets in her therapeutic approach.
Career Highlights: Susan's illustrious career includes significant roles at Forma Therapeutics, Inc. and Forma Tm2, Inc. Throughout her professional journey, she has been at the forefront of research and development, driving innovations that pave the way for new treatment modalities in cancer therapy. Her extensive patent portfolio reflects her commitment to addressing complex medical challenges through inventive solutions.
Collaborations: Susan has collaborated with esteemed colleagues in her field, including Wei Lu and Jian Lin. These partnerships have fostered a collaborative environment that enhances research capabilities and accelerates the development of novel therapeutic strategies.
Conclusion: Susan Ashwell's innovative spirit and dedication to advancing cancer treatment through targeted therapies solidify her status as a leading inventor. With her extensive patent portfolio and collaborative work within the pharmaceutical industry, she continues to inspire future generations of scientists and researchers committed to making a difference in the fight against cancer.